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Silibinin, a natural plant flavonolignan is the main active constituent found in milk thistle
(Silybum marianum). It is known to have hepatoprotective, anti-neoplastic effect, and
suppresses lipid accumulation in adipocytes. Objective of this study was to investigate
the effect of silibinin on adipogenic differentiation and thermogenic capacity of human
adipose tissue derived mesenchymal stem cells. Silibinin (10 μM) treatment, either at the
beginning or at the end of adipogenic differentiation, resulted in an increase of SIRT-1,
PPARα, Pgc-1α, and UCPs gene expression. Moreover, silibinin administration resulted
in a decrease of PPARγ, FABP4, FAS, and MEST/PEG1 gene expression during the
differentiation, confirming that this compound is able to reduce fatty acid accumulation
and adipocyte size. Our data showed that silibinin regulated adipocyte lipid metabolism,
inducing thermogenesis and promoting a brown remodeling in adipocyte. Taken
together, our findings suggest that silibinin increases UCPs expression by stimulation
of SIRT1, PPARα, and Pgc-1α, improved metabolic parameters, decreased lipid mass
leading to the formation of functional adipocytes.
Keywords: silibinin, brown adipocyte, thermogenesis, adipocyte, lipid metabolism, stem cells differentiation,
human adipose tissue derived mesenchymal stem cells
INTRODUCTION
Obesity is characterized by hypertrophic adipocytes producing low adiponectin and increased
tumor necrosis factor α (TNF-α) levels, which are associated with insulin resistance (Cantley, 2014;
Moreno-Indias and Tinahones, 2015). On the other hand, adipose tissue can also suppress weight
gain and metabolic disease through the action of specialized, heat-producing adipocytes (Harms
and Seale, 2013). To date, two types of adipose tissue are known to exist: white (WAT) and brown
(BAT) adipose tissue.WAT is widely distributed throughout the body, whereas BAT is present only
in limited parts of the body such as interscapular, axillary, superior cervical, and perirenal regions.
The physiological signiﬁcance of these adipose tissues is completely diﬀerent: WAT functions to
store energy excess as fat, whereas BAT serves to consume energy excess as heat (thermogenesis)
(Kajimura and Saito, 2014). Furthermore, brown adipocytes contain more capillaries compared to
white adipocytes and their brown color is due to the presence of many mitochondria in the cell
(Nam and Cooper, 2015).
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In brown fat, the heat-generating pathway is the futile
cycle of proton pumping through the actions of uncoupling
protein 1 (UCP1) (Rousset et al., 2004). In cells expressing
UCP1, the oxidation of lipids and carbohydrates results in the
extraction of high-energy electrons, which ﬂow down the electron
transport chain (ETC) as protons are pumped across the inner
mitochondrial membrane. Thus, much of the chemical energy
generated by substrates oxidation in brown fat cells triggers a
futile proton cycle leading to heat generation (Shabalina et al.,
2013).
The biomedical interest in brown adipocytes focused on the
capacity of these cell types to counteract metabolic disease,
including obesity and type 2 diabetes (Poher et al., 2015). Brown
adipocytes are located in speciﬁc areas and express constitutively
high levels of thermogenic genes, whereas inducible ‘brown-like’
adipocytes, also known as beige cells, have a white fat phenotype
and produce heat in response to various activators. Many genes
and pathways regulating brown and beige adipocyte biology
have now been identiﬁed, providing a variety of promising
therapeutic targets for metabolic disease (Masella et al., 2012;
Cohen and Spiegelman, 2015). Several natural and synthetic
compounds have been shown to be actively involved in such
pathways and among these, silibinin seems to be a very promising
agent. Recent studies have demonstrated that silibinin, a natural
plant ﬂavonolignan has an anti-adipogenic eﬀect on 3T3-L1
cells (Kim et al., 2009) and suppresses lipid accumulation in
adipocytes. In particular, a previous report showed that silibinin
regulates underlying signaling for hypertrophy and hyperplasia
in adipocyte, and anti-adipogenic eﬀect of silibinin was exerted
on early adipogenic stage during adipogenesis via cell cycle
arrest (Suh et al., 2015). Most of the studies utilized murine
3T3-L1 cell line for examination of adipocyte development as
these cells readily accumulate lipid upon diﬀerentiation (Christy
et al., 1989; Ntambi and Young-Cheul, 2000; Burton et al.,
2002). However, with the discovery of human adipose tissue
derived mesenchymal stem cells (ASCs; Zuk et al., 2001), this
multi-potent lineage has become the main focus for analyzing
changes during diﬀerentiation (DeLany et al., 2005; Yu et al.,
2010).
Objective of this study was to investigate the eﬀect of
silibinin on adipogenic diﬀerentiation and thermogenic capacity
of human adipose tissue derived mesenchymal stem cells.
MATERIALS AND METHODS
Adipose Stem Cells Isolation and Culture
Adipose tissue sample was obtained from a patient underwent
abdominal plastic surgery (male, 30 years old, 98 kg of body
weight); the subject provided his written consent before inclusion
in the study. Since this is a non-therapeutic trial, it was carried
out with the consent of the subject legally acceptable according
our Italian Government (Legge 675/1996 and DL 196/2003, art.
40. Art 32 Codice Italiano di Deontologia Medica). Adipose
tissue was minced with scissors and scalpels into less than
3-mm pieces and isolation of ASCs proceeded as previously
described (Salomone et al., 2013). Brieﬂy, after gentle shaking
TABLE 1 | PCR primers used in this study.
Gene Primer forward Primer reverse
Adiponectin AGGCTTTCCGGGAATCCAAG CGCTCTCCTTCCCCATACAC
DGAT1 CGCGGACTACAAATGGACGA AACCAGTAAGACCACAGCCG
DLK1 TCCTCAACAAGTGCGAGACC CTGTGGGAACGCTGCTTAGA
FABP4 AAACTGGTGGTGGAATGCGT GCGAACTTCAGTCCAGGTCA
FAS CGGAGGCATCAACCCAGATT GATGGTGGTGTAGACCTTCCG
GAPDH AGACACCATGGGGAAGGTGA TGGAATTTGCCATGGGTGGA
IL6 CTTCTCCACAAGCGCCTTCG CTGGCATTTGTGGTTGGGTC
IRS1 GCAACCAGAGTGCCAAAGTG AGGTCATTTAGGTCTTCAT
TCTGCT
PGC1α GGTGCAGTTTTGCCAAGGAG TTCCTTGGGGTCCAGACAGA
PPARα AAGAGCTTGGAGCTCGGC TGAAAGCGTGTCCGTGATGA
PPARγ AGAGTACGTGGGAGAAATGAC GATGGCCACCTCTTTGCTCT
SIRT1 TGATTGGCACAGATCCTCGAA AAGTCTACAGCAAGGCGAGC
TNF α CTCGAGTCAGATCATCTTCTCG
CACCCCG
GGAATTCTGTTCGTCCTCCT
CACAGGGC
UCP-1 TGTCCTGGGAACAATCACCG TCCAGGATCCAAGTCGCAAG
UCP-2 GCCTCTACAATGGGCTGGTT GAGCATGGTAAGGGCACAGT
UCP-3 AGCCCCCTCGACTGTATGAT ACTTTCATCAGGGCCCGTTT
with equal volume of PBS, the mixture separated into two
phases. The upper phase (containing stem cells, adipocytes, and
blood) after washing with PBS was enzymatically dissociated
with 0.075% collagenase (type I)/PBS for 1 h at 37◦C with
gentle shaking. The dissociated tissue was then mixed with an
equal volume of DMEM (GIBCO-BRL, Japan) supplemented
with 10% FBS and incubated 10 min at room temperature. The
solution then was separated into two phases. The lower phase was
centrifuged at 1500 rpm for 5 min at 20◦C. The cellular pellet
was resuspended in 160 mM NH4Cl to eliminate erythrocytes
and passed through a 40 μm mesh ﬁlter into a new tube. The
cells were resuspended in an equal volume of DMEM/10% FBS
and then centrifuged. Isolation resulted in obtaining 7.7 × 106
of adherent cells for a primary culture from 5 g of adipose
tissue (approximately; 1.0 × 105 to 4.6 × 106/1 g) after 7 to
10 days of culture. The cells were suspended in DMEM/10% FBS
plated in concentration 1–5 × 106 cells/75 cm2. The phenotype
of ASCs was evaluated by ﬂow-cytometry analysis (FC500
Beckman Coulter). The ASCs presented as a homogeneous
ﬁbroblastic cell population. Flow-cytometric analysis of passage
4th cells revealed that cells were negative for CD34 and CD45,
and that cells were positive for CD105 and CD90 (Data not
shown).
Differentiation of Human ASCs into
Adipocytes
Adipose tissue derived mesenchymal stem cells (passage 4 to 5)
were plated in a 75-cm2 ﬂask at a density of 1 to 2 × 104 cells and
cultured in DMEM with 10% FBS for 7 days. The medium was
replaced with adipogenic medium, and the cells were cultured for
an additional 7 or 14 days.
The adipogenic media consisted of complete culture medium
supplemented with DMEM-F12 high glucose, 3% (v/v) FBS,
100 nM insulin, 100 nM dexamethasone (Sigma–Aldrich, St.
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FIGURE 1 | (A–B) Lipid droplets accumulation measured by Oil red staining in differentiated cells in presence (B) or absence of silibinin (A). (C) Oil Red staining
measured by spectrophotometer (λ = 490 nm) in undifferentiated cells and after 14 Days of adipogenic differentiation in presence or absence of silibinin. (D) PPARγ
gene expression was evaluated by Real Time PCR. All values are expressed as mean ± SEM of four experiments (n = 4) in duplicate. ∗P < 0.05 vs. undifferentiated;
#P < 0.05 vs. differentiated.
Louis, MO, USA), 0.5 mM isobutylmethylxanthine (Sigma–
Aldrich, St. Louis, MO, USA), 60 μM indomethacin (Sigma–
Aldrich, St. Louis, MO, USA) and transferrin 10 μg/ml. Media
were changed every 3 days. Human ASCs were cultured in the
presence of Silibinin (10 μM) which was administered every
3 days in the ﬁrst set of experiments while for the second set
of experiments Silibinin was added for 24 h after 14 days of
adipogenic diﬀerentiation.
Oil Red O staining
Staining was performed using 0.21% Oil Red O in 100%
isopropanol (Sigma–Aldrich, St. Louis, MO, USA). Brieﬂy,
adipocytes were ﬁxed in 10% formaldehyde, stained with Oil Red
O for 10 min, rinsed with 60% isopropanol (Sigma–Aldrich), and
the Oil Red O eluted by adding 100% isopropanol for 10 min
and the optical density (OD) measured at 490 nm, for 0.5 s
reading. Lipid droplets accumulation was examined by using
inverted multichannel LED ﬂuorescence microscope (Evos, Life
Technologies, Grand Island, NY, USA).
RNA Extraction and qRT-PCR
RNA was extracted by Trizol reagent (Invitrogen, Carlsbad,
CA, USA). First strand cDNA was then synthesized with
Applied Biosystem (Foster City, CA, USA) reverse transcription
reagent.
Quantitative real-time PCR was performed in 7900HT
Fast Real-Time PCR System Applied Biosystems using the
SYBR Green PCR MasterMix (Life Technologies, Milan,
Italy). The primer sequences used are shown in Table 1.
The speciﬁc PCR products were detected by the ﬂuorescence
of SYBR Green, the double stranded DNA binding dye.
The relative mRNA expression level was calculated by
the threshold cycle (Ct) value of each PCR product and
normalized with that of GAPDH by using comparative 2−Ct
method.
Western Blot Analysis
Western Blot analysis was performed as previously described
(Vanella et al., 2013). Primary polyclonal antibodies directed
against UCP-1 and beta-actin were purchased from Santa
Cruz Technologies. Protein detection was carried out using
a secondary infrared ﬂuorescent dye conjugated antibody
absorbing at 800 nm or 700 nm. The blots were visualized
using an Odyssey Infrared Imaging Scanner (Li-Cor Science
Tec) and quantiﬁed by densitometric analysis performed after
normalization with b-actin.
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FIGURE 2 | Analysis of gene expression by Real time PCR of FABP4 (A), FAS (B), MEST/PEG1 (C), TNFα (D), IL-6 (E), and adiponectin (F). All values are
expressed as mean ± SEM of four experiments (n = 4) in duplicate. ∗P < 0.05 vs. undifferentiated; #P < 0.05 vs. differentiated.
Statistical Analysis
Statistical signiﬁcance (P < 0.05) of diﬀerences between
experimental groups was determined by the Fisher method
for analysis of multiple comparisons. For comparison between
treatment groups, the null hypothesis was tested by either single-
factor analysis of variance (ANOVA) for multiple groups, or the
unpaired t-test for two groups, and the data are presented as
mean± SEM.
FIGURE 3 | Analysis of gene expression by Real time PCR of SIRT1 (A), PPARα (B), PGC1α (C), UCP1 (D), UCP2 (E), and UCP3 (F). All values are
expressed as mean ± SEM of four experiments (n = 4) in duplicate. ∗P < 0.05 vs. undifferentiated; #P < 0.05 vs. differentiated.
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FIGURE 4 | Lipid droplets accumulation measured by Oil red staining in differentiated cells CTRL (A) and in differentiated cells treated for 24 h with
silibinin (B). Oil Red staining measured by spectrophotometer (λ = 490 nm) in differentiated cells and after silibinin treatment (C). All values are expressed as
mean ± SEM of four experiments (n = 4) in duplicate. ∗P < 0.05 vs. CTRL.
RESULTS
Analysis of Adipogenic Differentiation
To investigate signals that might regulate the diﬀerentiation of
ASCs, we analyzed the mRNA levels of peroxisome proliferator-
activated receptor gamma (PPARγ; Figure 1D), fatty acid
binding protein 4 (FABP4; Figure 2A), fatty acid synthase (FAS;
Figure 2B) and mesoderm-speciﬁc transcript (MEST/PEG1;
Figure 2C). We showed that all of these markers resulted in a
signiﬁcantly increase after 14 days of adipogenic diﬀerentiation.
In addition, Figures 1A–C shows positive Oil Red staining of the
cells following 14 days of diﬀerentiation.
The Effect of Silibinin on the
Adipogenesis
Quantiﬁcation of Oil Red stained cells showed that lipid droplets
decreased following Silibinin treatment (Figures 1A,B). As seen
in Figure 1C PPARγ was signiﬁcantly reduced by silibinin
treatment respect to the diﬀerentiated cells. Moreover, the
administration of silibinin during the adipogenic diﬀerentiation
was able to reduce signiﬁcantly the mRNA levels of PPARγ
(Figure 1C), FABP4 (Figure 2A), FAS (Figure 2B), MEST/PEG1
(Figure 2C), and Adiponectin (Figure 2F).
Silibinin Reduces TNF-α and Il-6
Expression
In order to study the potential anti-inﬂammatory eﬀects
of silibinin, we investigated TNF-α and IL-6 expression
during diﬀerentiation. We show a signiﬁcantly increase of
mRNA levels of these cytokines in diﬀerentiated adipocytes
(Figures 2D,E). Silibinin treatment was able to decrease
signiﬁcantly TNF-α and IL-6 mRNA levels in diﬀerentiated
cells.
Effect of Silibinin on Thermogenic Genes
Expression
In order to investigate the eﬀect of silibinin on lipid
metabolism, we analyzed the expression of the thermogenic
pathway markers. The administration of Silibinin during
adipogenic diﬀerentiation was able to signiﬁcantly
increase mRNA levels of sirtuin 1 (SIRT-1), peroxisome
proliferator-activated receptor alpha (PPARα) and peroxisome
proliferator-activated receptor gamma, co-activator 1
alpha (Pgc-1α) (Figures 3A–C). Moreover, to study the
activation of heat-generating pathway, which is the futile
cycle of proton pumping through the actions of UCPs,
we analyzed the expression of UCP1, UCP2, and UCP3.
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FIGURE 5 | Analysis of gene expression, evaluated by Real Time PCR, of cells treated with silibinin for 24 h after adipogenic differentiation. Each
graph (A–I) represents the relative expression of a single gene indicated on the Y axis compared to differentiated untreated cells. All values are expressed as
mean ± SEM of four experiments (n = 4) in duplicate. ∗P < 0.05 vs. DIFF.
These set of experiments showed that Silibinin was able to
signiﬁcantly increase the expression levels of UCP1, 2, and 3
(Figures 3D–F).
The Effect of Silibinin on Mature
Adipocytes
In a new set of experiments, we examined the eﬀect of Silibinin
on lipid accumulation after 14 days of diﬀerentiation by
measuring Red Oil-stained lipid droplet area (Figure 4).
Quantiﬁcation of Oil Red stained cells showed that lipid
droplets decreased following Silibinin treatment (24 h).
Furthermore, we observed a signiﬁcantly reduction of PPARγ
(Figure 5A), diacylglycerol O-acyltransferase 1 (DGAT1;
Figure 5D) and Delta like 1 (DLK-1) (Figure 5F) mRNA
levels following silibinin treatment (Figure 5A). Interesting,
silibinin showed a signiﬁcantly increase of FABP4, FAS,
and insulin receptor substrate 1 (IRS-1) genes expression
(Figure 5).
Consistently with the ﬁrst set of experiments, TNF-α and Il-
6 resulted in a signiﬁcantly decrease of mRNA levels following
silibinin treatment.
Silibinin Switches the Lipid Metabolism
of Adipocyte Toward the Thermogenic
Pathway
We found that all markers of thermogenic pathway of brown
adipocytes resulted in a signiﬁcantly increase following silibinin
treatment. In particular, in Figure 6 we showed that silibinin
administration for 24 h was able to increase the expression of
SIRT-1, PPARα, Pgc-1α, UCP-1, UCP-2, and UCP-3. Moreover,
the increased UCP-1 expression was further conﬁrmed by
Western Blot (Figure 6G).
DISCUSSION
Silibinin, a natural plant ﬂavonolignan is the main active
constituent found in milk thistle (Silybum marianum), a plant
of the Asteraceae family. In particular, it is known to have
hepatoprotective and anti-neoplastic eﬀect (Li Volti et al.,
2011; Marrazzo et al., 2011; Salamone et al., 2012). Ka et al.
(2009) have shown that silibinin inhibits adipogenesis of 3T3
cells by promoting the expression of insulin-induced genes
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FIGURE 6 | (A–F) Analysis of gene expression, evaluated by Real Time PCR, of cells treated with silibinin for 24 h after adipogenic differentiation. (G) Western Blot
analysis of UCP-1 expression in differentiated adipocytes following silibinin treatment. All values are expressed as mean ± SEM of four experiments (n = 4) in
duplicate. ∗P < 0.05 vs. DIFF.
1 and 2 (INSIG1 and INSIG2), which block activation of
sterol regulatory element binding protein-1c (SREBP1-c) (Kim
et al., 2009). Furthermore, Suh et al. (2015) identiﬁed anti-
adipogenic eﬀect of silibinin in zebraﬁsh via the down-regulation
of adipogenic factors and the reduction of lipid accumulation
in adipocyte and it is thought to be due to the regulation of
silibinin on the phosphorylation of AMP-activated protein kinase
alpha (AMPKa) and Acetyl-CoA carboxylase (ACC) (Suh et al.,
2015). Adipocyte diﬀerentiation and its impact on restriction or
expansion of particular adipose tissue depots have physiological
and pathophysiological signiﬁcance in view of the diﬀerent
functions of these depots. Brown or “beige” fat expansion
can enhance thermogenesis, lipid oxidation, insulin sensitivity,
and glucose tolerance; conversely expanded visceral fat (VAT)
is associated with insulin resistance, low-grade inﬂammation,
dyslipidemia, and cardio metabolic risk.
In the present study we showed that silibinin treatment during
and at the end of adipogenic diﬀerentiation of ASC cell induces
thermogenesis pathway in adipocyte by activation of UCPs.
Our data showed that silibinin is able to switch the lipid
metabolism from white adipocytes phenotype to beige or
brown. Silibinin treatment, from the beginning or at the
end of adipogenic diﬀerentiation, resulted in an increase of
SIRT-1, PPARα, Pgc-1α, and UCPs. On the other hand, the
silibinin eﬀects resulted in a decrease of PPAR gamma, FABP4,
FAS, and MEST/PEG1 expression during the diﬀerentiation,
conﬁrming that its administration is able to reduce the fatty
acid accumulation and the size of the cells. Moreover, decreasing
in TNF-α and IL-6 expression in the diﬀerentiated adipocyte
treated with silibinin respect the untreated adipocyte conﬁrms
a reduction of inﬂammation (Figure 7). Consistently with
our ﬁndings previous reports showed that TNF-α inhibits
SIRT1 expression in human adipocytes (Serrano-Marco et al.,
2012). SIRT1, an NAD+ dependent type III deacetylase sirtuin,
enhances glucose tolerance by potentiating brown adipose
tissue function (Boutant et al., 2015) contributing to energy
expenditure and browning of WAT and resistance to dietary
obesity (Wang et al., 2013), interacts with PPARα and is
required to activate PGC-1α (Purushotham et al., 2009). PPARα
plays an important role in lipid metabolism, and activation of
PPARα in human WAT leds to the appearance of brown fat
gene expression, including UCP1 and PGC-1α (Mandard et al.,
Frontiers in Pharmacology | www.frontiersin.org 7 January 2016 | Volume 6 | Article 309
Barbagallo et al. Silibinin and Adipose Tissue Differentiation
FIGURE 7 | Scheme of the silibinin effects during adipogenic differentiation and in mature adipocytes. Adipogenic differentiation causes an increase in
TNFα, IL-6, FAS, FABP4, and MEST/PEG1 resulting in an increase of insulin resistance, inflammation, dyslipidemia, and cardiometabolic risk. Silibinin switches the
lipid metabolism of adipocyte to thermogenic pathway resulting in an improvement of insulin sensitivity and glucose tolerance.
2004; Hondares et al., 2011). PPARα has been considered a
distinctive marker of BAT with respect to the WAT phenotype
(Villarroya et al., 2007). Finally, in this pathway, Pgc-1α is
essential for cold-induced or β3-agonist-induced thermogenic
activation of brown adipocytes (Uldry et al., 2006) and the
expression of thermogenic genes in WAT (Kleiner et al., 2012).
In addition, we found a signiﬁcantly decrease of adiponectin
expression in adipocytes diﬀerentiated with silibinin. These
data are consistent with previously studies demonstrating that
adiponectin overexpression signiﬁcantly decreases UCP1 and
PGC-1α protein levels (Qiao et al., 2014). In order to study
the eﬀects of silibinin on the mature adipocytes we also treated
the cells at the end of diﬀerentiation. The mature adipocytes
treated with silibinin (24 h) showed a signiﬁcantly decrease
of fatty acid accumulation and of DGAT1 gene expression,
enzyme required for triacylglycerol synthesis and lipid droplets in
adipocytes (Harris et al., 2011). In contrast to what was observed
for silibinin treatment during the diﬀerentiation, FABP4 and
FAS gene expression resulted in a signiﬁcantly increase, which
could be a response to lipolytic eﬀect of silibinin. Moreover,
the expression of those enzymes involved in lipid uptake and
mobilization, favoring fatty acid utilization through uncoupled
respiration (Teruel et al., 2005). Furthermore, we found an
increase of IRS1 gene expression in adipocyte treated with
silibinin. This data are consistent with a recent study showing that
IRS-1 plays important roles in brown adipocyte diﬀerentiation
where defects in diﬀerentiation in the IRS-1 knockout cells
can be restored by reconstitution of these cells with IRS-1
(Tseng et al., 2004). In the present study, we also showed
the decrease of DLK1 gene expression by silibinin in mature
adipocytes. This gene is a molecular gatekeeper of adipogenesis
which acts by maintaining the pre-adipocyte state and preventing
adipocyte diﬀerentiation (Hudak and Sul, 2013). In addition,
it was demonstrated that DLK-1 preferentially inhibits heat
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production in brown adipose tissue (Rakhshandehroo et al.,
2012).
Our results showed that silibinin could induce
thermoregulation improving metabolic homeostasis. In
particular, silibinin modulated adipocytes lipid metabolism,
inducing thermogenesis and promoting a brown remodeling
of WAT. Taken together, our ﬁndings suggest that silibinin
increases UCPs expression by stimulation of SIRT1, PPARα,
and Pgc-1α, which might mediate the induction of higher
energy eﬃciency, improved metabolic parameters, decreased fat
mass and formation of functional adipocytes. In conclusion,
silibinin may serves as a potential pharmacological tool to
restore adipocyte function in metabolic diseases by acting as the
biochemical switching of adipocytes phenotype.
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